
8/16/2017 – The Valeant Pharmaceuticals (VRX) Trade
Even though I have owned Valeant Pharmaceuticals (VRX) through its horrendous downtrend from the $25 price level, I have been reluctant to discuss it much as I bought into the downtrend too early. (Take note 4 Stock Stinkers – don’t rush into downtrends. Even when they rebound, they usually re-test...